Vitamin D receptor gene polymorphisms in Iranian Azary patients with Behçet’s disease

References

• Davatchi F, Jamshidi AR, Banihashemi AT, Gholami J, Forouzanfar MH, Moradi M, et al. Prevalence of Behçet’s disease in Iran: a WHO-ILAR COPCORD stage I study. APLAR J Rheumatol 2007;10:239–43.
   Google Scholar
• Davatchi F, Jamshidi A-R, Banihashemi AT, Gholami J, Forouzanfar MH, Akhlaghi M, et al. WHO-ILAR COPCORD study (stage 1, urban study) in Iran. J Rheumatol 2008;35:1384–90.
   PubMed Web of Science ®Google Scholar
• Karatay S, Yildirim K, Karakuzu A, Kiziltunc A, Engin RI, Eren YB, et al. Vitamin D status in patients with Behçet’s disease. Clinics 2011;66:721–3.
   PubMed Web of Science ®Google Scholar
• Faezi ST, Ansari N, Paragomi P, Akhlaghi M, Ghanavat M, Davatchi F. Vitamin D deficiency in patients with Behçet’s disease. J Diabetes Metab Disord 2014;13:18.
   Google Scholar
• Hamzaoui K, Ben Dhifallah I, Karray E, Sassi F, Hamzaoui A. Vitamin D modulates peripheral immunity in patients with Behçet’s disease. Clin Exp Rheumatol 2009;28:S50–7.
   Google Scholar
• Do JE, Kwon SY, Park S, Lee E-S. Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behçet’s disease. Rheumatology (Oxford) 2008;47:840–8.
   PubMed Web of Science ®Google Scholar
• Khabbazi A, Rashtchizadeh N, Ghorbanihaghjo A, Hajialiloo M, Ghojazadeh M, Taei R, et al. The status of serum vitamin D in patients with active Behçet’s disease compared with controls. Int J Rheum Dis 2014;17:430–4.
   PubMed Web of Science ®Google Scholar
• Rigby W, Waugh M, Graziano R. Regulation of human monocyte HLA-DR and CD4 antigen expression, and antigen presentation by 1,25-dihydroxyvitamin D3. Blood 1990;76:189–97.
   PubMed Web of Science ®Google Scholar
• Berer A, Stöckl J, Majdic O, Wagner T, Kollars M, Lechner K, et al. 1,25-Dihydroxyvitamin D3 inhibits dendritic cell differentiation and maturation in vitro. Exp Hematol 2000;28:575–83.
   PubMed Web of Science ®Google Scholar
• Griffin MD, Lutz WH, Phan VA, Bachman LA, McKean DJ, Kumar R. Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem Biophys Res Commun 2000;270:701–8.
   PubMed Web of Science ®Google Scholar
• D’Ambrosio D, Cippitelli M, Cocciolo MG, Mazzeo D, Di Lucia P, Lang R, et al. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 1998;101:252–62.
   PubMed Web of Science ®Google Scholar
• Veldman CM, Cantorna MT, DeLuca HF. Expression of 1,25-Dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 2000;374:334–8.
   PubMed Web of Science ®Google Scholar
• Provvedini D, Tsoukas C, Deftos L, Manolagas S. 1,25-Dihydroxyvitamin D3 receptors in human leukocytes. Science 1983;221:1181–3.
   PubMed Web of Science ®Google Scholar
• Zmuda JM, Cauley JA, Ferrell RE. Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev 2000;22:203–17.
   PubMed Web of Science ®Google Scholar
• Zhang J, Chalmers MJ, Stayrook KR, Burris LL, Wang Y, Busby SA, et al. DNA binding alters coactivator interaction surfaces of the intact VDR-RXR complex. Nat Struct Mol Biol 2011;18:556–63.
   PubMed Web of Science ®Google Scholar
• Štefanić M, Karner I, Glavaš-Obrovac L, Papić S, Vrdoljak D, Levak G, et al. Association of vitamin D receptor gene polymorphism with susceptibility to Graves’ disease in Eastern Croatian population: case-control study. Croat Med J 2005; 46:639–46.
   PubMed Web of Science ®Google Scholar
• Horst-Sikorska W, Ignaszak-Szczepaniak M, Marcinkowska M, Kaczmarek M, Stajgis M, Slomski R. Association analysis of vitamin D receptor gene polymorphisms with bone mineral density in young women with Graves’ disease. Acta Biochim Pol 2008;55:371–80.
   PubMed Web of Science ®Google Scholar
• Filus A, Trzmiel A, Kuliczkowska-Plaksej J, Tworowska U, Jedrzejuk D, Milewicz A, et al. Relationship between vitamin D receptor BsmI and FokI polymorphisms and anthropometric and biochemical parameters describing metabolic syndrome. Aging Male 2008;11:134–9.
   PubMed Web of Science ®Google Scholar
• McCullough ML, Bostick RM, Mayo TL. Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer. Annu Rev Nutr 2009;29:111–32.
   PubMed Web of Science ®Google Scholar
• Mostowska A, Lianeri M, Wudarski M, Olesińska M, Jagodziński PP. Vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus. Mol Biol Rep 2013;40:803–10.
   PubMed Web of Science ®Google Scholar
• Lee YH, Bae S-C, Choi SJ, Ji JD, Song GG. Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Mol Biol Rep 2011;38:3643–51.
   PubMed Web of Science ®Google Scholar
• Hitchon CA, Sun Y, Robinson DB, Peschken CA, Bernstein CN, Siminovitch KA, et al. Vitamin D receptor polymorphism rs2228570 (Fok1) is associated with rheumatoid arthritis in North American natives. J Rheumatol 2012;39:1792–7.
   PubMed Web of Science ®Google Scholar
• Feng M, Li H, Chen S-F, Li W-F, Zhang F-B. Polymorphisms in the vitamin D receptor gene and risk of autoimmune thyroid diseases: a meta-analysis. Endocrine 2013;43:318–26.
   PubMed Web of Science ®Google Scholar
• Bid HK, Konwar R, Aggarwal C, Gautam S, Saxena M, Nayak VL, Banerjee M. Vitamin D receptor (FokI, BsmI and TaqI) gene polymorphisms and type 2 diabetes mellitus: a North Indian study. Indian J Med Sci 2009;63:187–94.
   PubMedGoogle Scholar
• Uitterlinden AG, Fang Y, van Meurs JB, Pols HA, van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene 2004;338:143–56.
   PubMed Web of Science ®Google Scholar
• Karray EF, Ben Dhifallah I, Ben Abdelghani K, Ben Ghorbel I, Khanfir M, Houman H, et al. Associations of vitamin D receptor gene polymorphisms FokI and BsmI with susceptibility to rheumatoid arthritis and Behçet’s disease in Tunisians. Joint Bone Spine 2012;79:144–8.
   PubMed Web of Science ®Google Scholar
• Davatchi F, Assaad-Khalil S, Calamia K, Crook J, Sadeghi-Abdollahi B, Schirmer M, et al. The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 2014;28:338–47.
   PubMed Web of Science ®Google Scholar
• Pani MA, Knapp M, Donner H, Braun J, Baur MP, Usadel KH, et al. Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes 2000; 49:504–7.
   PubMed Web of Science ®Google Scholar
• Aslani S, Hossein-Nezhad A, Mirzaei K, Maghbooli Z, Afshar AN, Karimi F. VDR FokI polymorphism and its potential role in the pathogenesis of gestational diabetes mellitus and its complications. Gynecol Endocrinol 2011;27:1055–60.
   PubMed Web of Science ®Google Scholar
• Capoluongo E, Pitocco D, Concolino P, Santonocito C, Di Stasio E, d’Onofrio G, et al. Slight association between type 1 diabetes and ‘ff’ VDR FokI genotype in patients from the Italian Lazio Region. Lack of association with diabetes complications. Clin Biochem 2006;39:888–92.
   PubMed Web of Science ®Google Scholar
• Pani MA, Seissler J, Usadel K-H, Badenhoop K. Vitamin D receptor genotype is associated with Addison’s disease. Eur J Endocrinol 2002;147:635–40.
   Google Scholar
• Mohammadnejad Z, Ghanbari M, Ganjali R, Afshari JT, Heydarpour M, Taghavi SM, et al. Association between vitamin D receptor gene polymorphisms and type 1 diabetes mellitus in Iranian population. Mol Biol Rep 2012;39:831–7.
   PubMed Web of Science ®Google Scholar
• Lemos MC, Fagulha A, Coutinho E, Gomes L, Bastos M, Barros L, et al. Lack of association of vitamin D receptor gene polymorphisms with susceptibility to type 1 diabetes mellitus in the Portuguese population. Hum Immunol 2008;69:134–8.
   PubMed Web of Science ®Google Scholar
• Fassbender W, Goertz B, Weismuller K, Steinhauer B, Stracke H, Auch D, et al. VDR gene polymorphisms are overrepresented in German patients with type 1 diabetes compared to healthy controls without effect on biochemical parameters of bone metabolism. Horm Metab Res 2002;34:330–7.
   PubMed Web of Science ®Google Scholar
• Smolders J, Damoiseaux J, Menheere P, Tervaert JWC, Hupperts R. Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis. J Neuroimmunol 2009;207:117–21.
   PubMed Web of Science ®Google Scholar
• Abbasi M, Rezaieyazdi Z, Afshari JT, Hatef M, Sahebari M, Saadati N. Lack of association of vitamin D receptor gene BsmI polymorphisms in patients with systemic lupus erythematosus. Rheumatol Int 2010;30:1537–9.
   PubMed Web of Science ®Google Scholar
• Niksresht A, Dadkhah B, Sarvestani EK. The association of vitamin D receptor gene BsmI polymorphism with multiple sclerosis in Iranian patients. J Kerman Univ Med Sci 2009;16:116–23.
   Google Scholar
• Sioka C, Papakonstantinou S, Markoula S, Gkartziou F, Georgiou A, Georgiou I, et al. Vitamin D receptor gene polymorphisms in multiple sclerosis patients in northwest Greece. J Negat Results Biomed 2011;10:3.
   PubMedGoogle Scholar
• Sakulpipatsin W, Verasertniyom O, Nantiruj K, Totemchokchyakarn K, Lertsrisatit P, Janwityanujit S. Vitamin D receptor gene BsmI polymorphisms in Thai patients with systemic lupus erythematosus. Arthritis Res Ther 2006;8:R48.
   Web of Science ®Google Scholar
• Huang C, Wu M, Wu J, Tsai F. Association of vitamin D receptor gene BsmI polymorphisms in Chinese patients with systemic lupus erythematosus. Lupus 2002;11:31–4.
   PubMed Web of Science ®Google Scholar
• Malecki M, Frey J, Moczulski D, Klupa T, Kozek E, Sieradzki J. Vitamin D receptor gene polymorphisms and association with type 2 diabetes mellitus in a Polish population. Exp Clin Endocrinol Diabetes 2003;111:505–9.
   PubMed Web of Science ®Google Scholar
• Jurutka PW, Remus LS, Whitfield GK, Thompson PD, Hsieh J-C, Zitzer H, et al. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol 2000; 14:401–20.
   PubMed Web of Science ®Google Scholar
• Colin EM, Weel AE, Uitterlinden AG, Buurman CJ, Birkenhäger JC, Pols HA, et al. Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1,25-dihydroxyvitamin D3. Clin Endocrinol 2000;52:211–16.
   PubMed Web of Science ®Google Scholar